Cargando…
A cancer therapeutic nanoparticle vaccine targeting HAAH improves 3-week survival from 12.5% to 100% in a mouse model of metastatic breast cancer
Autores principales: | Fuller, Steven, Lebowitz, Michael S, Stewart, Solomon, Ghanbari, Hossein A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288663/ http://dx.doi.org/10.1186/2051-1426-2-S3-P52 |
Ejemplares similares
-
Inhibition of tumor growth in vivo by a nanoparticle-based therapeutic cancer vaccine targeting HAAH
por: Fuller, Steven, et al.
Publicado: (2013) -
A nanoparticle therapeutic vaccine targeting HAAH stimulates cellular immunity
por: Lebowitz, Michael, et al.
Publicado: (2015) -
Immunogenicity of a lambda phage-based anti-cancer vaccine targeting HAAH
por: Fuller, Steven, et al.
Publicado: (2013) -
Enhanced immunogenicity of a nanoparticle therapeutic cancer vaccine targeting HAAH delivered intradermally using 3M's hollow microstructured transdermal system (hMTS)
por: Fuller, Steven, et al.
Publicado: (2015) -
Design, development and production of nano-particle-based anticancer vaccine targeting human aspartyl (asparaginyl) β-hydroxylase (HAAH)
por: Biswas, Biswajit, et al.
Publicado: (2013)